This Article Full Text (PDF) Other Versions of this Article: IAI.01528-06v1 75/4/1745    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yoder, J. M. Articles by Mantis, N. J. Search for Related Content PubMed PubMed Citation Articles by Yoder, J. M. Articles by Mantis, N. J.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.01528-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Murine model of intestinal ricin intoxication: Evidence for widespread epithelial damage and coincident production of monocyte chemotactic protein-1

Division of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY 12208

^* To whom correspondence should be addressed. Email: nmantis{at}wadsworth.org.

	Abstract

The development of small animal models is necessary to understand host responses and immunity to emerging infectious diseases and potential bioterrorism agents. In this report we have characterized a murine model of intestinal ricin intoxication. Ricin administered intragastrically (i.g.) to BALB/c mice at doses ranging from 1 to 10 mg/kg induced dose-dependent morphological changes in the proximal small intestine (i.e., duodenum), including widespread villus atrophy and epithelial damage. Coincident with epithelial damage was a localized increase in monocyte chemotactic protein-1 (MCP-1), a chemokine known to be associated with inflammation of the intestinal mucosa. Immunity to intestinal ricin intoxication was achieved by immunizing mice i.g. with ricin toxoid, and correlated with elevated levels of anti-toxin mucosal IgA and serum IgG antibodies. We conclude that the mouse model we have developed will serve as a valuable tool in identifying the inflammatory pathways and protective immune responses that are elicited in the intestinal mucosa following ricin exposure, and will prove useful in the evaluation of anti-toxin vaccines and therapeutics.

This article has been cited by other articles:

• Surendranath, K., Karande, A. A. (2008). A Neutralizing Antibody to the A Chain of Abrin Inhibits Abrin Toxicity both In Vitro and In Vivo. CVI 15: 737-743 [Abstract] [Full Text]